drugset / Trial / NCT01150266
Study for the Use of Alteplase in Patients Who Awaken With Stroke
Phase 1
Withdrawn
University of California, San Diego
National Institute of Neurological Disorders and Stroke (NINDS) · collabScripps Health · collab
NaSingle-groupOpen-labelTreatment
Summary
This is a pilot study of thrombolytic therapy in patients with ischemic stroke who present with stroke symptoms upon awakening.
Timeline
- Start
- 2011-08
- Primary completion
- 2013-09
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alteplase | Protein / enzyme biologic | 0.9 mg/kg | Intravenous |